Literature DB >> 15328149

Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis.

Ivana Munitic1, Joy A Williams, Yili Yang, Bei Dong, Philip J Lucas, Nahed El Kassar, Ronald E Gress, Jonathan D Ashwell.   

Abstract

Interleukin-7 receptor (IL-7R) levels are tightly controlled during ontogeny: high on double-negative (DN) cells, absent on double-positive (DP) cells, and high once again on thymocytes undergoing positive selection. To determine if loss of IL-7-mediated survival signals in DP cells is necessary for normal antigen-specific selection, we created T-lineage-specific IL-7R alpha chain (IL-7Ralpha) transgenic (Tg) mice in which IL-7R is expressed throughout ontogeny. There was no effect of the IL-7Ralpha Tg on negative selection. Surprisingly, however, although the thymi of IL-7Ralpha Tg mice were comparable at birth, there was a decrease in thymocyte number as the mice aged. This was found to be due to competition between DN and IL-7R-expressing DP cells for endogenous IL-7, which resulted in decreased levels of Bcl-2 in DN cells, increased DN apoptosis, and decreased DN cell number. Therefore, the down-regulation of IL-7R on DP cells is an "altruistic" act required for maintaining an adequate supply of local IL-7 for DN cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328149     DOI: 10.1182/blood-2004-06-2484

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

2.  c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner.

Authors:  Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

3.  Ephrinb1 and Ephrinb2 are associated with interleukin-7 receptor α and retard its internalization from the cell surface.

Authors:  Hongyu Luo; Zenghui Wu; Shijie Qi; Wei Jin; Bing Han; Jiangping Wu
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

4.  LKB1 regulates TCR-mediated PLCγ1 activation and thymocyte positive selection.

Authors:  Yonghao Cao; Hai Li; Haifeng Liu; Min Zhang; Zichun Hua; Hongbin Ji; Xiaolong Liu
Journal:  EMBO J       Date:  2011-04-12       Impact factor: 11.598

5.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 6.  Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development.

Authors:  Changwan Hong; Megan A Luckey; Jung-Hyun Park
Journal:  Semin Immunol       Date:  2012-03-14       Impact factor: 11.130

Review 7.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

8.  Oral glucocorticoid treatment decreases interleukin-10 receptor expression on peripheral blood leucocyte subsets.

Authors:  M Moniuszko; A Bodzenta-Lukaszyk; M Dabrowska
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

9.  T-cell differentiation of multipotent hematopoietic cell line EML in the OP9-DL1 coculture system.

Authors:  Snjezana Kutlesa; Jennifer Zayas; Alexandra Valle; Robert B Levy; Roland Jurecic
Journal:  Exp Hematol       Date:  2009-05-15       Impact factor: 3.084

10.  CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia.

Authors:  Sara González-García; Marina García-Peydró; Enrique Martín-Gayo; Esteban Ballestar; Manel Esteller; Rafael Bornstein; José Luis de la Pompa; Adolfo A Ferrando; María L Toribio
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.